Back to mobile site
Get it on Google Play

TransCode Therapeutics to present TTX-MC138 trial data at ESMO 2026

October 19, 2026 8:04 AM EDT Send to a Friend
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announced that a poster presenting Phase 1a clinical trial data for its lead drug candidate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login